{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:55:19Z","timestamp":1774677319808,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clinthera.2023.06.004","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T01:43:42Z","timestamp":1689299022000},"page":"702-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Protocol for a Prospective, Observational Cost-effectiveness Analysis of Returning Secondary Findings of Genome Sequencing for Unexplained Suspected Genetic Conditions"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0762-0101","authenticated-orcid":false,"given":"Wendy J.","family":"Ungar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin Z.","family":"Hayeems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian R.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith K.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Szuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"James Stavropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Jarinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vercancy","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Tsiplova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynnette","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whiwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viji","family":"Venkataramanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Mendoza-Londono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Somerville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kym M.","family":"Boycott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.06.004_bib0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41525-018-0053-8","article-title":"Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases","volume":"3","author":"Clark","year":"2018","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npjgenmed.2015.12","article-title":"Whole genome sequencing expands diagnostic utility and improves clinical management in pediatric medicine","volume":"1","author":"Stavropoulos","year":"2016","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.clinthera.2023.06.004_sbref0003","series-title":"Anticipate and Communicate Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts","year":"2013"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0004","first-page":"1407","article-title":"ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"24","author":"Miller","year":"2022","journal-title":"Gen Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0005","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jmedgenet-2015-103144","article-title":"The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists","volume":"52","author":"Boycott","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0006","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ejhg.2013.46","article-title":"Whole-genome sequencing in health care: Recommendations of the European Society of Human Genetics","volume":"21","author":"van El","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0007","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10897-017-0172-x","article-title":"Impact of receiving secondary results from genomic research: A 12-month longitudinal study","volume":"27","author":"Wynn","year":"2018","journal-title":"J Genet Couns"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0008","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/gim.2018.35","article-title":"Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial","volume":"20","author":"Christensen","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0009","first-page":"1100","article-title":"Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study","volume":"21","author":"Hart","year":"2019","journal-title":"Gen Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ejhg.2016.178","article-title":"Psychological and behavioural impact of returning personal results from whole-genome sequencing: the HealthSeq project","volume":"25","author":"Sanderson","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0011","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ajhg.2018.07.018","article-title":"Evaluation of recipients of positive and negative secondary findings evaluations in a hybrid CLIA-research sequencing pilot","volume":"103","author":"Sapp","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0012","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41431-020-0694-9","article-title":"Secondary findings in inherited heart conditions: a genotype-first feasibility study to assess phenotype, behavioural and psychosocial outcomes","volume":"28","author":"Ormondroyd","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2019.103711","article-title":"Secondary findings from next generation sequencing: Psychological and ethical issues, family and patient perspectives","volume":"62","author":"Houdayer","year":"2019","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2018.08.010","article-title":"Secondary findings from whole-exome\/genome sequencing evaluating stakeholder perspectives. A review of the literature","volume":"62","author":"Delanne","year":"2019","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12920-021-01016-8","article-title":"Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings","volume":"14","author":"Cl\u00e9ophat","year":"2021","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0016","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.gim.2022.02.018","article-title":"Impact of returning unsolicited genomic results to nongenetic health care providers in the eMERGE III Network","volume":"24","author":"Madden","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0017","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.gim.2022.02.004","article-title":"Perspectives and preferences regarding genomic secondary findings in underrepresented prenatal and pediatric populations: A mixed-methods approach","volume":"24","author":"Rego","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.864822","article-title":"Whole exome sequencing in South Africa: Stakeholder views on return of individual research results and incidental findings","volume":"13","author":"Van Der Merwe","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0019","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pd.6097","article-title":"A framework for reporting secondary and incidental findings in prenatal sequencing: When and for whom?","volume":"42","author":"Vears","year":"2022","journal-title":"Prenatal diagnosis"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/gim.2014.156","article-title":"The cost-effectiveness of returning incidental findings from next-generation genomic sequencing","volume":"17","author":"Bennette","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0021","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/medethics-2016-103564","article-title":"Parents perspectives on whole genome sequencing for their children: Qualified enthusiasm?","volume":"43","author":"Anderson","year":"2016","journal-title":"J Med Ethics"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002316","article-title":"From Genotype to Phenotype","volume":"11","author":"Mackley","year":"2018","journal-title":"Circulation Genomic and Precision Medicine"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0023","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41431-018-0106-6","article-title":"Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study","volume":"26","author":"Mackley","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0024","first-page":"124","article-title":"Secondary findings from next-generation sequencing: what does actionable in childhood really mean?","volume":"21","author":"Richer","year":"2019","journal-title":"Gen Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/gim.2017.157","article-title":"Not pathogenic until proven otherwise\": perspectives of UK clinical genomics professionals toward secondary findings in context of a genomic medicine multidisciplinary team and the 100,000 Genomes Project","volume":"20","author":"Ormondroyd","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0026","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejmg.2018.11.029","article-title":"Views from the clinic: Healthcare provider perspectives on whole genome sequencing in paediatrics","volume":"62","author":"Szego","year":"2019","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0027","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/gim.2016.109","article-title":"Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: A systematic review of quantitative and qualitative studies","volume":"19","author":"Mackley","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0028","series-title":"A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder","author":"Jegathisawaran","year":"2019"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0029","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/gim.2017.47","article-title":"A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder","volume":"19","author":"Tsiplova","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0030","series-title":"A microcosting and cost-consequence analysis of genomic testing strategies in developmental delay and autism spectrum disorder","author":"Tsiplova","year":"2016"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0031","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40258-018-0390-x","article-title":"Cost-effectiveness of genome and exome sequencing in children diagnosed with autism spectrum disorder","volume":"16","author":"Yuen","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0032","series-title":"Microcosting of whole genome sequencing (WGS) of trios in a heterogeneous pediatric cardiac population","author":"Jegathisawaran","year":"2020"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0033","first-page":"1027","article-title":"Whole genome trio sequencing for developmental delay and pediatric heart conditions: A comparative microcost analysis","volume":"24","author":"Jegathisawaran","year":"2022","journal-title":"Gen Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0034","series-title":"Genome-wide sequencing for unexplained developmental disabilities or multiple congenital anomalies: A health technology assessment","first-page":"1","year":"2020"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0035","first-page":"451","article-title":"Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies","volume":"23","author":"Li","year":"2021","journal-title":"Gen Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0036","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40258-018-0436-0","article-title":"Family spillover effects in pediatric cost-utility analyses","volume":"17","author":"Lavelle","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0037","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40273-019-00794-5","article-title":"Advances in methods and novel applications for measuring family spillover effects of illness","volume":"37","author":"Prosser","year":"2019","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0038","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40273-019-00768-7","article-title":"Spillover effects on caregivers' and family members' utility: A systematic review of the literature","volume":"37","author":"Wittenberg","year":"2019","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0039","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/children8050346","article-title":"Incorporating cascade effects of genetic testing in economic evaluation: A scoping review of methodological challenges","volume":"8","author":"Cernat","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0040","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/s41431-021-00952-4","article-title":"Cascade health service use in family members following genetic testing in children: a scoping literature review","volume":"29","author":"Cernat","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0041","doi-asserted-by":"crossref","first-page":"E460","DOI":"10.9778\/cmajo.20210272","article-title":"Comparing genome sequencing technologies to improve rare disease diagnostics: A protocol for the evaluation of a pilot project, Genome-wide Sequencing Ontario","volume":"10","author":"Hayeems","year":"2022","journal-title":"CMAJ Open."},{"key":"10.1016\/j.clinthera.2023.06.004_bib0042","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13073-018-0607-5","article-title":"Prevalence of pathogenic\/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls","volume":"10","author":"Kim","year":"2018","journal-title":"Genome Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0043","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jpeds.2017.01.049","article-title":"Psychosocial response to uncertain newborn screening results for cystic fibrosis","volume":"184","author":"Hayeems","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0044","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1052","article-title":"Parent experience with false-positive newborn screening results for cystic fibrosis","volume":"138","author":"Hayeems","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0045","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41431-022-01192-w","article-title":"Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: Further evidence of validity","volume":"30","author":"Hayeems","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.clinthera.2023.06.004_bib0046","first-page":"430","article-title":"The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): Preliminary evidence of validity and reliability","volume":"24","author":"Hayeems","year":"2022","journal-title":"Gen Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0047","first-page":"95","article-title":"The development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE): A novel strategy for measuring the clinical utility of genetic testing","volume":"22","author":"Hayeems","year":"2020","journal-title":"Gen Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0048","series-title":"Encyclopedia of Social Measurement","first-page":"715","article-title":"Survey Design","author":"Wagenaar","year":"2005"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0049","first-page":"694","article-title":"The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real world evidence","volume":"24","author":"Hayeems","year":"2022","journal-title":"Gen Med"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0050","first-page":"1096","article-title":"Genome diagnostics: Novel strategies for measuring value","volume":"25","author":"Hayeems","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.clinthera.2023.06.004_sbref0051","series-title":"List of publicly available Canadian cost information","year":"2021"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0052","series-title":"Consumer Price Index, monthly, percentage change, not seasonally adjusted, Canada, provinces, Whitehorse and Yellowknife \u2014 Health and personal care","year":"2022"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0053","series-title":"Guidelines for the Economic Evaluation of Health Technologies: Canada 4th Edition","year":"2017"},{"key":"10.1016\/j.clinthera.2023.06.004_bib0054","unstructured":"Income of individuals by age group, sex and income source, Canada, provinces and selected census metropolitan areas. Ottawa, Canada: Statistics Canada; 2022."},{"key":"10.1016\/j.clinthera.2023.06.004_bib0055","unstructured":"Evidence to improve care: Ontario genetics advisory committee: Health Quality Ontario; 2022 Available from: https:\/\/www.hqontario.ca\/Evidence-to-Improve-Care\/Health-Technology-Assessment\/Ontario-Genetics-Advisory-Committee."},{"key":"10.1016\/j.clinthera.2023.06.004_bib0056","unstructured":"Health Technology Review Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health; 2023 Available from: https:\/\/www.cadth.ca\/health-technology-review."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823001960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823001960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:58:46Z","timestamp":1758963526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0149291823001960"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.06.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for a Prospective, Observational Cost-effectiveness Analysis of Returning Secondary Findings of Genome Sequencing for Unexplained Suspected Genetic Conditions","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}